Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study-Reference-Cited by-同舟云学术

Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study

Published:2023-05-04 Issue:5 Volume:62 Page:488-494
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Hirata Takero¹^ORCID,Suzuki Osamu¹,Otani Keisuke¹,Miyake Akimitsu²³,Tamari Keisuke¹^ORCID,Seo Yuji¹,Isohashi Fumiaki¹,Kai Naoki⁴,Hatano Koji⁵,Fujita Kazutoshi⁵,Uemura Motohide⁵,Imamura Ryoichi⁵,Tamenaga Setsuo¹,Yoshino Yutaro¹,Fumimoto Yasutoshi¹,Yoshioka Yasuo⁶,Nonomura Norio⁵,Ogawa Kazuhiko¹

Affiliation:

1. Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan

2. Department of Medical Innovation, Osaka University Hospital, Osaka, Japan

3. Department of AI and Innovative Medicine, Tohoku University School of Medicine, Miyagi, Japan

4. Department of Medical Technology, Osaka University Hospital, Osaka, Japan

5. Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan

6. Department of Radiation Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Funder

Japan Society for the Promotion of Science KAKENHI

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2213443

Reference28 articles.

1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

2. Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patients

3. Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

4. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

5. Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal/genitourinary adverse event after intensity modulated versus three-dimensional primary radiation therapy in the treatment of prostate cancer: systematic review and meta-analysis;Journal of Cancer;2023